| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3297252 | Gastroenterology | 2011 | 13 Pages |
Abstract
Signaling of the chemokine CCL25 through its receptor CCR9 induces Tregs to migrate to the intestine. These findings raise concerns about the development of reagents to disrupt this pathway for the treatment of patients with Crohn's disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Joshua D. Wermers, Eoin N. McNamee, Marc-André Wurbel, Paul Jedlicka, Jesús Rivera-Nieves,